SCLC

Clinical trials for SCLC explained in plain language.

Never miss a new study

Get alerted when new SCLC trials appear

Sign up with your email to follow new studies for SCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 11 Not yet recruiting 1 Not yet finished but already full! 7 Completed 1 Terminated 1

New drug combo aims to outperform standard care in aggressive lung cancer

Disease control Not yet recruiting

This Phase 3 trial will test whether a new drug called BL-M14D1 combined with atezolizumab works better than the current standard treatment for people with extensive-stage small cell lung cancer who have not had prior therapy. About 550 adults will be randomly assigned to receive…

Matched conditions: SCLC

Phase: PHASE3 • Sponsor: SystImmune Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC

SCLC

Get alerted when new SCLC trials appear

New drug combo aims to outperform standard care in aggressive lung cancer